Mozobil 20 mg

MOZOBIL 20 MG is a subcutaneous solution containing plerixafor, used to mobilize stem cells for medical procedures. This medication is manufactured by Sanofi-Aventis Canada Inc.

MOZOBIL 20 MG is primarily used to mobilize hematopoietic stem cells into the bloodstream. This process is often part of preparations for stem cell transplants or other related medical procedures. The active ingredient, plerixafor, works by stimulating the movement of these cells from the bone marrow to the blood.

Common effects of MOZOBIL 20 MG may include temporary discomfort at the injection site, such as redness or swelling. Some individuals might experience mild to moderate side effects like headache, nausea, or diarrhea. These effects are generally short-lived and resolve on their own.

MOZOBIL 20 MG should be administered by healthcare professionals experienced in stem cell mobilization procedures. It is important to follow the prescribed guidelines for storage and handling to maintain the integrity of the solution. Always consult with a healthcare provider before use.

MOZOBIL 20 MG may interact with other medications, particularly those that affect the immune system or blood cell production. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of plerixafor.